A Simplified Thromboplastin Calibration Procedure for Standardization of Anticoagulant Control^[*]

Summary

In thromboplastin calibration, the possibility of replacing fresh individual plasmas by pooled fresh plasmas (used immediately after preparation or after storage at —25° C) or by pooled lyophilized plasmas has been investigated. It was found that the thromboplastin sensitivity ratios (TSR’s) assessed with pooled fresh plasmas show no divergence from those obtained with the original Biggs/Denson calibration procedure. With pooled lyophilized plasmas a small divergence can be found in particular with so-called PIVKA-insensitive rabbit-tissue thromboplastins. Since, in contrast to the original procedure, only a limited number of determinations with pooled fresh or lyophilized plasmas are needed to obtain an accurate TSR value, the modification substantially simplifies thromboplastin calibration. Moreover, the technique using lyophilized plasmas can be applied in laboratories where an insufficient number of patients are available or none at all. However, as long as pooled lyophilized plasmas display a more or less pronounced activation, it might be preferable to restrict calibration to qualified expert laboratories, i.e. national reference laboratories.

The merits of pooled lyophilized plasma are those of good stability even under the condition of accelerated degradation. They might be just as useful as thromboplastins for use as (long-term) reference material in the standardization and quality control program of manufacturers of thromboplastins, and for laboratorians preparing their own thromboplastin for the anticoagulant control.

Conditions for the preparation and use of lyophilized reference plasmas have been worked out and are presented.

^* E. A. Loeliger, Afd. Haemostase en Thromboseonderzoek, Interne Geneeskunde, Academisch Ziekenhuis Leiden, The Netherlands.

• References

• 1 Bangham D. R, Biggs R, Brozović M, Denson K. W. E. Draft report of a collaborative study of two thromboplastins (including the use of common abnormal plasma). Thrombosis et Diathesis Haemorrhagica (Stuttg.) Suppl. 1970; 40: 341
• 2 Bangham D. R, Biggs R, Brozović M, Denson K. W. E. Calibration of five different thromboplastins using fresh and freeze-dried plasma. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 1973; 29: 228
• 3 Biggs R, Denson K. W. E. Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. British Medical Journal 1967; 1: 84
• 4 BrozoviĆ M, Howarth D. J, van Halem-Visser L. P, Loeliger E. A. Stability of freeze-dried plasma prepared from patients on oral anticoagulants. Journal of Clinical Pathology 1974; 26: 857 (1973)
• 5 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haematologica 1957; 17: 237
• 6 Davey R. E, Fiske M. L, Maltby A. Evaluation of a photoelectric automatic prothrombin analyzer. American Journal of Clinical Pathology 1972; 58: 687
• 7 Denson K. W. E. International and national standardization of control of anticoagulant therapy in patients receiving coumarin and indanedione drugs using calibrated thromboplastin preparations. Journal of Clinical Pathology 1971; 24: 460
• 8 Fewell R. G, Cundy A, Jenkins G. C. The one-stage prothrombin test: a comparative study of a mechanized prothrombin-meter and manual testing. Medical Laboratory Technology 1972; 29: 147
• 9 Loeliger E. A. Personal experience 1972
• 10 Loeliger E. A, Hemker H. C. Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy. Thrombosis et Diathesis Haemorrhagica Suppl. 1969; 15: 101
• 11 Loeliger E. A, Meuwisse-Braun J. B, Muis H, Buitendijk F. J. J, Veltkamp J. J, Hemker H. C. Laboratory control on oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations. Thrombosis et Diathesis Haemorrhagica (Stuttg.) 1970; 23: 569
• 12 Miale J. B, Kent J. W. Performance characteristics of reference thromboplastins. American Journal of Clinical Pathology 1973; 60: 453
• 13 Owren P. A, Aas K. The control of Dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinavian Journal of Clinical and Laboratory Investigation 1951; 3: 201
• 14 Poller L. Progress in laboratory control of anticoagulant treatment. In: Poller L. (ed.). Recent Advances in Blood Coagulation. J. and A. Churchill Ltd.; London: 1969: 146
• 15 Quick A. J, Leu M. Quantitative Determination of Prothrombin. Journal of Biological Chemistry 1937; 119: LXXXI.
• 16 Sibley C, Singer J. W. Comparison of the fibrometer system and the bio/ data coagulation analyzer. American Journal of Clinical Pathology 1972; 57: 369
• 17 Zucker S, Cathey M. H, West B. Preparation of quality control specimens for coagulation. American Journal of Clinical Pathology 1970; 53: 924